GEN Exclusives

More »

GEN News Highlights

More »
Aug 6, 2007

J&JPRD to Apply Melior’s In Vivo Models

  • Melior Discovery’s theraTRACESM indications discovery platform will be used to identify possible new indications for multiple Johnson & Johnson Pharmaceutical Research & Development (J&JPRD) drug candidates.

    The theraTRACE platform is a multiplexed set of integrated in vivo models that systematically test the potential efficacy of compounds across a large number of disease models. It reduces the time, amount of test compound, and number of test subjects needed while also reducing the number of false positive results, according to the companies.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Using CRISPRs to Tame GMOs

With more climate-induced droughts and insect infestations on the horizon do you think technologies like CRISPR will change a lot of people’s minds about GMOs, including genetically engineered foods?

More »